ES8507449A1 - Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol - Google Patents

Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol

Info

Publication number
ES8507449A1
ES8507449A1 ES532802A ES532802A ES8507449A1 ES 8507449 A1 ES8507449 A1 ES 8507449A1 ES 532802 A ES532802 A ES 532802A ES 532802 A ES532802 A ES 532802A ES 8507449 A1 ES8507449 A1 ES 8507449A1
Authority
ES
Spain
Prior art keywords
butanol
hydroxybutoxy
pharmaceutical compositions
pure
methylpropoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532802A
Other languages
English (en)
Spanish (es)
Other versions
ES532802A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Luso Farmaco dItalia SpA
Original Assignee
Istituto Luso Farmaco dItalia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Luso Farmaco dItalia SpA filed Critical Istituto Luso Farmaco dItalia SpA
Publication of ES532802A0 publication Critical patent/ES532802A0/es
Publication of ES8507449A1 publication Critical patent/ES8507449A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/132—Saturated ethers containing hydroxy or O-metal groups both carbon chains being substituted by hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES532802A 1983-05-30 1984-05-25 Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol Expired ES8507449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21352/83A IT1164254B (it) 1983-05-30 1983-05-30 3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione

Publications (2)

Publication Number Publication Date
ES532802A0 ES532802A0 (es) 1985-10-01
ES8507449A1 true ES8507449A1 (es) 1985-10-01

Family

ID=11180528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532802A Expired ES8507449A1 (es) 1983-05-30 1984-05-25 Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol

Country Status (8)

Country Link
US (1) US4584321A (enExample)
JP (1) JPS604146A (enExample)
BE (1) BE899790A (enExample)
DE (1) DE3419947A1 (enExample)
ES (1) ES8507449A1 (enExample)
FR (1) FR2547813B1 (enExample)
GB (1) GB2142623B (enExample)
IT (1) IT1164254B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410802B1 (en) * 1999-04-01 2002-06-25 Esperion Therapeutics, Inc. Methods for synthesizing ether compounds and intermediates therefor
CA2425121A1 (en) 2000-10-11 2002-04-18 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CN1479721A (zh) 2000-10-11 2004-03-03 ͨ��ҽ�ƹ�˾ 用于胆固醇治疗和相关应用的亚砜和双亚砜化合物和组合物
MXPA03003022A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de sulfuro y disulfuro y composiciones para el control del colesterol y usos relacionados.
JP2004511453A (ja) 2000-10-11 2004-04-15 エスペリオン　セラピューティクス，インコーポレイテッド コレステロールの制御及び関連する使用のためのケトン化合物及び組成物
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
MXPA04009831A (es) * 2002-04-10 2004-12-07 Esperion Therapeutics Inc Imitaciones de la coenzima-a de acilo, composiciones de las mismas y metodos de manejo del colesterol y usos relacionados.
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
US7705177B2 (en) 2003-12-24 2010-04-27 Esperion Therapuetics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CN103848726B (zh) * 2012-12-09 2017-09-05 河北凯盛医药科技有限公司 一种高纯度二羟二丁基醚及其制备方法
CN103304383B (zh) * 2013-06-18 2015-04-08 重庆医科大学 保胆健素的新合成方法
CN103319316B (zh) * 2013-06-24 2015-06-10 大连理工大学 一种二羟基二丁醚的绿色制备方法
CN103333057A (zh) * 2013-06-24 2013-10-02 大连理工大学 一种二羟基二丁醚的制备方法
CN104230674A (zh) * 2014-08-28 2014-12-24 成都邦泽生物医药科技有限公司 一种二羟基二丁醚的制备方法
AU2016233485B2 (en) 2015-03-13 2021-05-20 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and Ezetimibe and methods of treating or reducing the risk of cardiovascular disease
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
WO2020257573A1 (en) 2019-06-21 2020-12-24 Esperion Therapeutics, Inc. Salt forms of bempedoic acid and methods for using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT957008B (it) * 1967-11-09 1973-10-10 Luso Farmaco Inst Processo per la preparazione di eteri simmetrici di glicoli re canti ossidrili primari e secon dari
DE2218935C3 (de) * 1972-04-19 1980-01-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von wäßrigen Lösungen von N-Vinylpyrrolidonpolymerisaten

Also Published As

Publication number Publication date
IT8321352A1 (it) 1984-11-30
US4584321A (en) 1986-04-22
BE899790A (fr) 1984-11-30
IT1164254B (it) 1987-04-08
GB2142623A (en) 1985-01-23
ES532802A0 (es) 1985-10-01
GB2142623B (en) 1987-04-15
GB8411356D0 (en) 1984-06-06
JPS6241702B2 (enExample) 1987-09-04
DE3419947A1 (de) 1984-12-06
IT8321352A0 (it) 1983-05-30
JPS604146A (ja) 1985-01-10
FR2547813B1 (fr) 1989-01-27
DE3419947C2 (enExample) 1987-11-26
FR2547813A1 (fr) 1984-12-28

Similar Documents

Publication Publication Date Title
ES8507449A1 (es) Procedimiento de obtencion del 3-(3-hidroxibutoxi)-1-butanol
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
ES8401009A1 (es) Procedimiento para la preparacion de 2-(p-isobutil-fenil)propionato de 2-hidroxi-3-(o-metoxi-fenoxi)propilo.
GR77915B (enExample)
AU8599091A (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-y1-amine derivatives and their preparation
GR3031659T3 (en) Enniatines and enniatine derivates used to control endoparasites.
AU663200B2 (en) New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them
ES8608535A1 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
IL98133A0 (en) Sulphonyl substituted benzo-naphthyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3172298D1 (en) Pharmaceutical compositions
ES8301967A1 (es) Procedimiento de preparar compuestos carbostirilicos.
ES8702371A1 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
ES8403910A1 (es) Procedimiento para la preparacion de nitratos de amino-deso-xi-1.4;3.6-dianhidro-hexito,asi como de sus sales de adicionacida farmacologicamente inocuas
HUT49614A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
ES8105053A1 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
MY137475A (en) Chemical compounds.
AU654300B2 (en) 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation
DE3062201D1 (en) Antimycotic compositions containing imidazolylenol ethers, their preparation and their use
DE3470313D1 (en) Antibiotic, its preparation and its use
ZA874470B (en) New tetrahydrobenzothiazoles,and the preparation and use thereof
ES8204980A1 (es) Procedimietno para la preparacion de salicilato de lidocaina monohidrato.
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
ES8501734A1 (es) Un procedimiento para preparar derivados de cicloalquenilo